Financials
Financial year 2025
Revenue
€ 11.3 million
▲ 139% vs 2024
Profit
Caution€ -141,203
▼ 143% vs 2024
Debts
Normal€ 5.1 million
▲ 183% vs 2024
ULTIMEDI from Wingene, company number BE0834340946, closed financial year 2025 with a result of € -141,203 after tax. For that financial year ULTIMEDI recorded revenue of € 11.3 million and equity of € 1.9 million. Compared with financial year 2024, the result moved from € 330,890 to € -141,203. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
What happened at ULTIMEDI?
What happened at ULTIMEDI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 141,203 (▼ 143% vs 2024). Source: NBB ↗
- Bobbie Pharmaceutical Services BV became a director. NBB
- Bobbie Company BV stepped down as director. NBB
- Cecile Hoogmartens became a director. NBB
- CéVéGé BV became a director. NBB
- Bobbie Company BV became a director. NBB
- New establishment in Wingene. KBO
- Start of the company according to the CBE. KBO
In short
From € 744,332 profit in 2022 to € 141,203 loss in 2025.
Paid € 785,689 in corporate taxes since 2022.
Best year ever: 2023, with € 753,178 profit.
On average € 77,400 of value added per employee in 2024.
A new publication or filing at ULTIMEDI? We notify you, reason included.
Follow ULTIMEDINeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ULTIMEDI are Bobbie Pharmaceutical Services BV, Cecile Hoogmartens and CéVéGé BV. The shares are held by Bobbie Pharmaceutical Services (100%).
Directors
According to the 2025 annual accounts
Bobbie Pharmaceutical Services BV
Managing director · represented by Benoit Devroe
Also active at: BOFAR, Farmadistri, VERGEL +3 more
since 2025
since 2023
Director · represented by Chris Verstraete
Also active at: BOFAR, Bobbie Pharmaceutical Services, VERGEL +1 more
since 2023
Managing director · represented by Benoit Devroe
Also active at: BOFAR, Bobbie Pharmaceutical Services, VERGEL +1 more
since 2023 · until 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Flandria 5
8750 Wingene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0834.340.946
- VAT number
- BE 0834.340.946
- Registered office
- Flandria 5, 8750 Wingene
- Names & denominations
- ULTIMEDI
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 March 2011
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen